Krystal Biotech, Inc. (KRYS) stock
KRYSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 11/3042% above fair value
$305.23−0.45 (-0.15%)
Close on Nov 13, 2026Market cap $9.03BP/E 41.4Yield –
Krystal Biotech statistics
89 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Jan 11, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 6.29
- 2.22
- P/OCF Ratio
- 27.89
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 17.28
- 2.57
- EV / EBIT
- 35.70
- 19.31
- EV / FCF
- 26.20
- 22.27
Share statisticsIndustry
- Shares Change (YoY)
- 2.44%
- 10.8%
- Shares Change (QoQ)
- 0.12%
- 0.50%
- Float
- 25M
- 49M
- Shares Held by Insiders
- 17.2%
- 11.7%
- Shares Held by Institutions
- 102.4%
- 56.4%
Short sellingIndustry
- Short Interest
- 3M
- –
- Short Interest Change
- 3.71%
- -0.80%
- Short % of Float
- 12.4%
- 9.01%
- Short % of Shares Outstanding
- 10.3%
- 6.30%
- Days to Cover
- 12.23
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $382.54
- –
- 52-Week Low
- $198.02
- –
- 20-Day Moving Average
- $312.71
- –
- 50-Day Moving Average
- $326.77
- –
- 200-Day Moving Average
- $309.71
- –
- Average True Range (14)
- $11.13
- –
- Price Change (1 Week)
- 1.45%
- -1.15%
- Price Change (1 Month)
- -7.51%
- -4.87%
- Price Change (3 Months)
- -9.08%
- -21.0%
- Price Change (6 Months)
- -0.35%
- -20.6%
- Price Change (YTD)
- 23.8%
- -23.6%
- Price Change (1 Year)
- 50.3%
- -22.4%
- Price Change (3 Years)
- 196.9%
- -29.5%
- Price Change (5 Years)
- 542.6%
- -77.9%
- Average Volume (10 Days)
- 377,673
- –
- Average Volume (20 Days)
- 316,069
- –
- Average Volume (90 Days)
- 357,301
- –
- Relative Volume
- 0.31
- 0.70
- Relative Strength Index (14)
- 43.0
- 43.4
- Volatility (1 Year)
- 39.3%
- 80.1%
- Beta (5 Years)
- 0.84
- 1.07
MarginsIndustry
- Pretax Margin
- 55.1%
- -11.6%
- EBITDA Margin
- 48.4%
- -27.7%
- FCF Margin
- 66.0%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- 17.5%
- -49.9%
- Return on Assets (ROA)
- 15.9%
- -40.6%
- Return on Invested Capital (ROIC)
- 42.6%
- -32.9%
- Return on Capital Employed (ROCE)
- 15.8%
- -37.9%
Financial positionIndustry
- Current Ratio
- 7.89
- 3.30
- Quick Ratio
- 7.35
- 2.39
GrowthIndustry
- Revenue Growth (YoY)
- 26.0%
- 6.82%
- Net Income Growth (YoY)
- 13.2%
- -14.4%
- EPS Growth (YoY)
- 10.5%
- -12.3%
- FCF Growth (YoY)
- 87.3%
- 6.85%
EfficiencyIndustry
- Asset Turnover
- 0.33
- 0.40
- Revenue Per Employee
- $1.59M
- $429.29K
- Profits Per Employee
- $763.28K
- -$689.41K
- Employee Count
- 295
- 74
- WACC
- 9.31%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- $258.80M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $911.90M
- $17.76M
- Net Cash Per Share
- $30.81
- $0.80
- Equity (Book Value)
- $1.44B
- $53.89M
- Book Value Per Share
- $48.50
- $1.50
- Tangible Book Value
- $1.44B
- $27.13M
- Working Capital
- $979.62M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$13.85M
- -$1.00M
- FCF Per Share
- $10.48
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 2.49%
- -21.8%
- FCF Yield
- 3.43%
- -9.44%
Taxes and interestIndustry
- Income Tax
- $33.63M
- $73.00K
- Effective Tax Rate
- 13.0%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $89.68
- $19.34
- Graham Upside
- -70.6%
- -46.6%
- Altman Z-Score
- 37.71
- 0.23
- Piotroski F-Score
- 6
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | KRYS | S&P 500 | Difference | KRYS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -5.0% | -3.0% | −1.9 pts | ||
| 3 months | -7.0% | -2.8% | −4.3 pts | ||
| Year to date | +23.8% | +11.5% | +12.3 pts | ||
| 1 year | +51.7% | +13.5% | +38.2 pts | ||
| 3 years | +206.2% | +77.7% | +128.5 pts | +45.2% | +21.1% |
| 5 years | +542.6% | +72.6% | +470.0 pts | +45.1% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
3M KRYS shares were sold short on Oct 30, 2026, up 3.7% from the previous report, or 12.43% of the shares available to trade. At recent volumes it would take 12.2 days to buy them back. Over the last 20 sessions, 74.8% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 3,044,878 | +3.7% | 248,952 | 12.2 |
| Oct 15, 2026 | 2,936,047 | -15.5% | 284,209 | 10.3 |
| Sep 30, 2026 | 3,475,527 | +9.9% | 310,502 | 11.2 |
| Sep 15, 2026 | 3,163,642 | -5.5% | 239,129 | 13.2 |
| Aug 31, 2026 | 3,347,813 | +4.5% | 219,245 | 15.3 |
| Aug 14, 2026 | 3,204,909 | +0.1% | 310,636 | 10.3 |
| Jul 31, 2026 | 3,202,260 | -8.4% | 770,966 | 4.2 |
| Jul 15, 2026 | 3,496,648 | -0.6% | 307,160 | 11.4 |
| Jun 30, 2026 | 3,517,595 | +12.1% | 489,255 | 7.2 |
| Jun 15, 2026 | 3,138,292 | -0.3% | 288,945 | 10.9 |
| May 29, 2026 | 3,147,863 | -1.1% | 194,305 | 16.2 |
| May 15, 2026 | 3,183,527 | +2.8% | 397,230 | 8.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?